Newron Pharmaceuticals SpA (NWRN)

Switzerland
1.45
-0.08(-5.23%)
  • Volume:
    2,126
  • Bid/Ask:
    1.42/1.45
  • Day's Range:
    1.45 - 1.54
  • Type:Equity
  • Market:Switzerland
  • ISIN:IT0004147952
  • S/N:2791431

NWRN Overview

Prev. Close
1.53
Day's Range
1.45-1.54
Revenue
5.83M
Open
1.54
52 wk Range
1.2-2.57
EPS
-0.84
Volume
2,126
Market Cap
25.88M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
8,622
P/E Ratio
-
Beta
1.21
1-Year Change
-40%
Shares Outstanding
17,845,345
Next Earnings Date
14 Sept 2022
What is your sentiment on Newron Pharmaceuticals?
or
Market is currently closed. Voting is open during market hours.

Newron Pharmaceuticals SpA Company Profile

Newron Pharmaceuticals SpA Company Profile

Employees
25

Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson’s disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resistant schizophrenia; and Ralfinamide for orphan indication in neuropathic pain. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellSellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell